Ajanta Pharma Limited
AJANTPHARM
Classifica tra le azioni
#3707
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited... Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.
Prezzo delle azioni
$36.33
Capitalizzazione di mercato
$4.54B
Variazione (1 giorno)
-0.20%
Variazione (1 anno)
30.66%
Paese
IN
Scambia Ajanta Pharma Limited (AJANTPHARM)
Categoria
Healthcare
Utile per Ajanta Pharma Limited (AJANTPHARM)
Utile nel Jun 2026 TTM: $164.80M
Secondo gli ultimi rapporti finanziari di Ajanta Pharma Limited, gli utili attuali della società sono $164.80M. Nel 2024, la società ha registrato un utile di $133.59M, un aumento rispetto a agli utili del 2023, che erano di $90.68M. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Storico degli utili di Ajanta Pharma Limited dal 2005 al 2026
Utile alla fine di ogni anno
| Anno | Utile | Cambia |
|---|---|---|
| 2026 (TTM) | $164.80M | 18.53% |
| 2025 | $139.04M | 4.08% |
| 2024 | $133.59M | 47.31% |
| 2023 | $90.68M | -24.31% |
| 2022 | $119.81M | -2.57% |
| 2021 | $122.97M | 39.52% |
| 2020 | $88.14M | 19.01% |
| 2019 | $74.06M | -22.54% |
| 2018 | $95.62M | -4.34% |
| 2017 | $99.95M | 20.97% |
| 2016 | $82.63M | 13.06% |
| 2015 | $73.08M | 32.80% |
| 2014 | $55.03M | 69.13% |
| 2013 | $32.54M | 81.39% |
| 2012 | $17.94M | 41.32% |
| 2011 | $12.69M | 47.07% |
| 2010 | $8.63M | 46.96% |
| 2009 | $5.87M | -18.63% |
| 2008 | $7.22M | 61.49% |
| 2007 | $4.47M | 39.66% |
| 2006 | $3.20M | 48.67% |
| 2005 | $2.15M | 0.00% |
Utile per aziende simili o concorrenti
| Azienda | Utile | Differenza negli utili | Il paese |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $1.76B | 970.72% |
IN
|
